Evidence map›Paper›PMID 38139140›Full record

ArticleInternational journal of molecular sciences2023

Biosynthesis of the Inner Core of

Jesús Pérez-Ortega, Ria van Boxtel, Michel Plisnier, Dominique Ingels, Nathalie Devos, Steven Sijmons, Jan Tommassen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jesús Pérez-OrtegaSection Molecular Microbiology, Department of Biology, Faculty of Science, Utrecht University, 3584 CH Utrecht, The Netherlands.ORCID 0000-0002-8022-499X
Ria van BoxtelSection Molecular Microbiology, Department of Biology, Faculty of Science, Utrecht University, 3584 CH Utrecht, The Netherlands.
Michel PlisnierVaccines Research & Development, GSK, 1330 Rixensart, Belgium.
Dominique IngelsVaccines Research & Development, GSK, 1330 Rixensart, Belgium.
Nathalie DevosVaccines Research & Development, GSK, 1330 Rixensart, Belgium.
Steven SijmonsVaccines Research & Development, GSK, 1330 Rixensart, Belgium.
Jan TommassenSection Molecular Microbiology, Department of Biology, Faculty of Science, Utrecht University, 3584 CH Utrecht, The Netherlands.ORCID 0000-0001-7633-4945
GlaxoSmithKline (Belgium) · BEUtrecht University · NL

Funding

Dutch Research Council 14921
6 · The paper itself

Abstract

Previously developed whole-cell vaccines against

Indexed as

Bordetella pertussisLipopolysaccharidesToll-Like Receptor 4Cell DivisionEndotoxinsEscherichia coliHumansLipid AMutationPhosphatesWhooping CoughEndotoxinsLipid ALipopolysaccharidesPhosphatesToll-Like Receptor 43-deoxy-D-manno-oct-2-ulosonic acid (Kdo)Bordetella pertussiscell divisionendotoxinKdo kinaseKdo transferaselipid A phosphataselipopolysaccharidephosphoethanolamine transferaseToll-like receptor 4

Identifiers

PMID38139140
PMCPMC10743493
OpenAlexW4389566353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.